Bioabsorbable Stents Market By Material 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Bioabsorbable Stents Market
Bioabsorbable Stents Market: By Material (Polymeric, Metallic); By Application (Coronary Artery Disease, Peripheral Artery Disease); By End- User (General Hospitals, Cardiac Centers, Surgical Centers) & By Geography-Forecast (2016-2021)
Report Code : HCR 0252
Updated Date: 23 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Bioabsorbable Stents Market Overview
   1.1. Introduction
   1.2. Classification
2. Executive Summary
3. Bioabsorbable Stents Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. Patent Analysis
      3.2.3. Financials of Key Players
4. Bioabsorbable Stents Market Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
   4.3. Attractiveness of the Industry
      4.3.1. Suppliers Power
      4.3.2. Bargaining Power of Buyer
      4.3.3. Threat from New Entrants
      4.3.4. Threats from Substitutes
      4.3.5. Degree of Competition
5. Bioabsorbable Stents Market – Strategic Analysis
   5.1. Supply Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
6. Bioabsorbable Stents Market– By Material
   6.1. Polymeric Stents
   6.2. Metallic Stents
      6.2.1. Iron
      6.2.2. Zinc
      6.2.3. Magnesium
7. Bioabsorbable Stents Market– By Application
   7.1. Coronary Artery Disease
   7.2. Peripheral Artery Disease
8. Bioabsorbable Stents Market– By End-User
   8.1. General Hospitals
   8.2. Cardiac Centers
   8.3. Surgical Centers
9. Bioabsorbable Stents Market-Geographic Analysis
   9.1. Introduction 
   9.2. North America
      9.2.1. U.S.
      9.2.2. Canada
      9.2.3. Mexico
   9.3. Europe
      9.3.1. U.K.
      9.3.2. Germany
      9.3.3. France
      9.3.4. Rest of Europe
   9.4. APAC
      9.4.1. China
      9.4.2. Japan
      9.4.3. India
      9.4.4. Rest of APAC
   9.5. RoW
      9.5.1. South America
      9.5.2. Middle East
      9.5.3. Africa
10. Market Entropy
11. Company Profiles (Overview, Financials, Developments and Product Portfolio) 
         
   11.1. Abbott Laboratories
   11.2. Elixir Medical Corporation
   11.3. Boston Scientific Corporation
   11.4. Kyoto Medical Planning Co., Ltd.
   11.5. Amaranth Medical, Inc.
   11.6. REVA Medical, Inc.
   11.7. Biotronik SE & Co. KG
   11.8. Arterial Remodelling Technologies SA
   11.9. Meril Life Sciences Pvt. Ltd.
   11.10. Tepha Inc.
   11.11. Arterius Limited
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Stents are commonly used in the treatment of blocked arteries. Bioabsorbable stents are defined as fully biodegradable stents that completely disappear overtime. Despite the progression in normal metallic stents, there have been concerns on stent thrombosis and mismatch of stent with vessel size. To overcome these roadblocks biodegradable stents came into existence in the recent years and is expected to considerably replace traditional stents. They eradicate the need for dual anti-platelet therapies and treat coronary artery diseases more efficiently.

Bioabsorbable implant stents can be used as a delivery device for agents such as drugs and genes, and will perhaps play a role in the treatment of vulnerable plaque. Increasing occurrences of coronary and peripheral artery diseases coupled with increased commercialization of these products especially in the developed nations is driving the growth of the market. This market report is classified on the basis of various parameters. This report contains market segments categorized on the basis of material, application, end user and geography. The bioabsorbable stents market is classified on the basis of material used for manufacturing the products including polymeric and metallic.

Increasing focus on clinical trials of stents, aging population and technological advancements in treatments are the key drivers for the market growth. Metal bioabsorbable stents are luring the medical device providers as they have the potential to perform similarly to stainless steel metal stents. So far, two bioabsorbable metal alloys have been commercialized for this application: iron and magnesium. Zinc is being investigated and has been proven more efficient with fewer side effects. North America and Europe held major shares due to product availability, high standards of healthcare and constant innovation related to stents. APAC is set to witness huge growth with a CAGR of XX% in the next few years with the expanding healthcare and treatment centers in this region.

The key players in bioabsorbable stents market include:
  • Abbot Laboratories
  • Elixir Medical Corporation
  • Reva Medical, Inc.
  • Kyoto Medical Planning Co., Ltd.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll